Cargando…
Validation of a score tool for measurement of histological severity in juvenile dermatomyositis and association with clinical severity of disease
OBJECTIVES: To study muscle biopsy tissue from patients with juvenile dermatomyositis (JDM) in order to test the reliability of a score tool designed to quantify the severity of histological abnormalities when applied to biceps humeri in addition to quadriceps femoris. Additionally, to evaluate whet...
Autores principales: | , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4283618/ https://www.ncbi.nlm.nih.gov/pubmed/24064003 http://dx.doi.org/10.1136/annrheumdis-2013-203396 |
_version_ | 1782351288771543040 |
---|---|
author | Varsani, Hemlata Charman, Susan C Li, Charles K Marie, Suely K N Amato, Anthony A Banwell, Brenda Bove, Kevin E Corse, Andrea M Emslie-Smith, Alison M Jacques, Thomas S Lundberg, Ingrid E Minetti, Carlo Nennesmo, Inger Rushing, Elisabeth J Sallum, Adriana M E Sewry, Caroline Pilkington, Clarissa A Holton, Janice L Wedderburn, Lucy R |
author_facet | Varsani, Hemlata Charman, Susan C Li, Charles K Marie, Suely K N Amato, Anthony A Banwell, Brenda Bove, Kevin E Corse, Andrea M Emslie-Smith, Alison M Jacques, Thomas S Lundberg, Ingrid E Minetti, Carlo Nennesmo, Inger Rushing, Elisabeth J Sallum, Adriana M E Sewry, Caroline Pilkington, Clarissa A Holton, Janice L Wedderburn, Lucy R |
author_sort | Varsani, Hemlata |
collection | PubMed |
description | OBJECTIVES: To study muscle biopsy tissue from patients with juvenile dermatomyositis (JDM) in order to test the reliability of a score tool designed to quantify the severity of histological abnormalities when applied to biceps humeri in addition to quadriceps femoris. Additionally, to evaluate whether elements of the tool correlate with clinical measures of disease severity. METHODS: 55 patients with JDM with muscle biopsy tissue and clinical data available were included. Biopsy samples (33 quadriceps, 22 biceps) were prepared and stained using standardised protocols. A Latin square design was used by the International Juvenile Dermatomyositis Biopsy Consensus Group to score cases using our previously published score tool. Reliability was assessed by intraclass correlation coefficient (ICC) and scorer agreement (α) by assessing variation in scorers’ ratings. Scores from the most reliable tool items correlated with clinical measures of disease activity at the time of biopsy. RESULTS: Inter- and intraobserver agreement was good or high for many tool items, including overall assessment of severity using a Visual Analogue Scale. The tool functioned equally well on biceps and quadriceps samples. A modified tool using the most reliable score items showed good correlation with measures of disease activity. CONCLUSIONS: The JDM biopsy score tool has high inter- and intraobserver agreement and can be used on both biceps and quadriceps muscle tissue. Importantly, the modified tool correlates well with clinical measures of disease activity. We propose that standardised assessment of muscle biopsy tissue should be considered in diagnostic investigation and clinical trials in JDM. |
format | Online Article Text |
id | pubmed-4283618 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-42836182015-01-08 Validation of a score tool for measurement of histological severity in juvenile dermatomyositis and association with clinical severity of disease Varsani, Hemlata Charman, Susan C Li, Charles K Marie, Suely K N Amato, Anthony A Banwell, Brenda Bove, Kevin E Corse, Andrea M Emslie-Smith, Alison M Jacques, Thomas S Lundberg, Ingrid E Minetti, Carlo Nennesmo, Inger Rushing, Elisabeth J Sallum, Adriana M E Sewry, Caroline Pilkington, Clarissa A Holton, Janice L Wedderburn, Lucy R Ann Rheum Dis Basic and Translational Research OBJECTIVES: To study muscle biopsy tissue from patients with juvenile dermatomyositis (JDM) in order to test the reliability of a score tool designed to quantify the severity of histological abnormalities when applied to biceps humeri in addition to quadriceps femoris. Additionally, to evaluate whether elements of the tool correlate with clinical measures of disease severity. METHODS: 55 patients with JDM with muscle biopsy tissue and clinical data available were included. Biopsy samples (33 quadriceps, 22 biceps) were prepared and stained using standardised protocols. A Latin square design was used by the International Juvenile Dermatomyositis Biopsy Consensus Group to score cases using our previously published score tool. Reliability was assessed by intraclass correlation coefficient (ICC) and scorer agreement (α) by assessing variation in scorers’ ratings. Scores from the most reliable tool items correlated with clinical measures of disease activity at the time of biopsy. RESULTS: Inter- and intraobserver agreement was good or high for many tool items, including overall assessment of severity using a Visual Analogue Scale. The tool functioned equally well on biceps and quadriceps samples. A modified tool using the most reliable score items showed good correlation with measures of disease activity. CONCLUSIONS: The JDM biopsy score tool has high inter- and intraobserver agreement and can be used on both biceps and quadriceps muscle tissue. Importantly, the modified tool correlates well with clinical measures of disease activity. We propose that standardised assessment of muscle biopsy tissue should be considered in diagnostic investigation and clinical trials in JDM. BMJ Publishing Group 2015-01 2013-09-24 /pmc/articles/PMC4283618/ /pubmed/24064003 http://dx.doi.org/10.1136/annrheumdis-2013-203396 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 3.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/3.0/ |
spellingShingle | Basic and Translational Research Varsani, Hemlata Charman, Susan C Li, Charles K Marie, Suely K N Amato, Anthony A Banwell, Brenda Bove, Kevin E Corse, Andrea M Emslie-Smith, Alison M Jacques, Thomas S Lundberg, Ingrid E Minetti, Carlo Nennesmo, Inger Rushing, Elisabeth J Sallum, Adriana M E Sewry, Caroline Pilkington, Clarissa A Holton, Janice L Wedderburn, Lucy R Validation of a score tool for measurement of histological severity in juvenile dermatomyositis and association with clinical severity of disease |
title | Validation of a score tool for measurement of histological severity in juvenile dermatomyositis and association with clinical severity of disease |
title_full | Validation of a score tool for measurement of histological severity in juvenile dermatomyositis and association with clinical severity of disease |
title_fullStr | Validation of a score tool for measurement of histological severity in juvenile dermatomyositis and association with clinical severity of disease |
title_full_unstemmed | Validation of a score tool for measurement of histological severity in juvenile dermatomyositis and association with clinical severity of disease |
title_short | Validation of a score tool for measurement of histological severity in juvenile dermatomyositis and association with clinical severity of disease |
title_sort | validation of a score tool for measurement of histological severity in juvenile dermatomyositis and association with clinical severity of disease |
topic | Basic and Translational Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4283618/ https://www.ncbi.nlm.nih.gov/pubmed/24064003 http://dx.doi.org/10.1136/annrheumdis-2013-203396 |
work_keys_str_mv | AT varsanihemlata validationofascoretoolformeasurementofhistologicalseverityinjuveniledermatomyositisandassociationwithclinicalseverityofdisease AT charmansusanc validationofascoretoolformeasurementofhistologicalseverityinjuveniledermatomyositisandassociationwithclinicalseverityofdisease AT licharlesk validationofascoretoolformeasurementofhistologicalseverityinjuveniledermatomyositisandassociationwithclinicalseverityofdisease AT mariesuelykn validationofascoretoolformeasurementofhistologicalseverityinjuveniledermatomyositisandassociationwithclinicalseverityofdisease AT amatoanthonya validationofascoretoolformeasurementofhistologicalseverityinjuveniledermatomyositisandassociationwithclinicalseverityofdisease AT banwellbrenda validationofascoretoolformeasurementofhistologicalseverityinjuveniledermatomyositisandassociationwithclinicalseverityofdisease AT bovekevine validationofascoretoolformeasurementofhistologicalseverityinjuveniledermatomyositisandassociationwithclinicalseverityofdisease AT corseandream validationofascoretoolformeasurementofhistologicalseverityinjuveniledermatomyositisandassociationwithclinicalseverityofdisease AT emsliesmithalisonm validationofascoretoolformeasurementofhistologicalseverityinjuveniledermatomyositisandassociationwithclinicalseverityofdisease AT jacquesthomass validationofascoretoolformeasurementofhistologicalseverityinjuveniledermatomyositisandassociationwithclinicalseverityofdisease AT lundbergingride validationofascoretoolformeasurementofhistologicalseverityinjuveniledermatomyositisandassociationwithclinicalseverityofdisease AT minetticarlo validationofascoretoolformeasurementofhistologicalseverityinjuveniledermatomyositisandassociationwithclinicalseverityofdisease AT nennesmoinger validationofascoretoolformeasurementofhistologicalseverityinjuveniledermatomyositisandassociationwithclinicalseverityofdisease AT rushingelisabethj validationofascoretoolformeasurementofhistologicalseverityinjuveniledermatomyositisandassociationwithclinicalseverityofdisease AT sallumadrianame validationofascoretoolformeasurementofhistologicalseverityinjuveniledermatomyositisandassociationwithclinicalseverityofdisease AT sewrycaroline validationofascoretoolformeasurementofhistologicalseverityinjuveniledermatomyositisandassociationwithclinicalseverityofdisease AT pilkingtonclarissaa validationofascoretoolformeasurementofhistologicalseverityinjuveniledermatomyositisandassociationwithclinicalseverityofdisease AT holtonjanicel validationofascoretoolformeasurementofhistologicalseverityinjuveniledermatomyositisandassociationwithclinicalseverityofdisease AT wedderburnlucyr validationofascoretoolformeasurementofhistologicalseverityinjuveniledermatomyositisandassociationwithclinicalseverityofdisease AT validationofascoretoolformeasurementofhistologicalseverityinjuveniledermatomyositisandassociationwithclinicalseverityofdisease |